Related Pages on the Web

National Human Genome Research Institute: DNA Chip Technology Fact Sheet
National Human Genome Research Institute: DNA Microarray Technology
The Pharmacogenomics Journal
Pharmacogenomics From the Ground Up, Session 1: Concepts and Tools in Pharmacogenomics
Genomics at FDA, Background Information on Genomics
Personalized Medicine: What is it? How will it affect health care? 11th Annual FDA Science Forum
FDA Consumer Magazine: Genomics and Personalized Medicine

Article Sources

S1
Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

S2
Cattaneo, D. et. al. (2004 March 2). From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy [48 paragraphs]. Medscape from Am J Transplant 4(3):299-310, 2004 [On-line journal]. Available FTP: http://www.medscape.com/viewarticle/470038

S3
(2006 February 27, Modified). Pharmacogenomics [17 paragraphs ]. Human Genome Project Information [On-line information]. Available FTP: http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml

S4
Ma, M. et. al. (2002 December 2). Genetic Basis of Drug Metabolism [31 paragraphs]. Medscape from Am J Health-Syst Pharm 59(21):2061-2069, 2002 [On-line journal]. Available FTP: http://www.medscape.com/viewarticle/444804

S5
Pharmacogenomics: A Clinician's Primer on Emerging Technologies for Improved Patient Care [20 paragraphs]. Mayo Communiqué [On-line information]. Available FTP: http://www.mayoreferenceservices.org/media-comm/apr2002.pdf#search='pharmacogenomics'

S6
Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part one [32 paragraphs]. PriceWaterhouseCoopers [On-line information]. Available FTP: http://www.pwc.com/extweb/execpers.nsf/docid/1FABC5BA1F9A885F85257088006230C1

S7
Lefteroff, T. (© 2005). Personalised medicine: The emerging pharmacogenomics revolution, part two [35 paragraphs]. PriceWaterhouseCoopers [On-line information]. Available FTP: http://www.pwc.com/extweb/execpers.nsf/docid/E918DAA0105A2939852570E00079022E

S8
(2003 November 3). FDA Issues Guidance on Pharmacogenomics Data [9 paragraphs]. FDA News [On-line information]. Available FTP: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00969.html

S9
Vega, C. (2004). The AAFP Focuses on Genomics [36 paragraphs]. Highlights of the American Academy of Family Physicians 2004 Scientific Assembly and the 17th World Conference of Family Doctors [On-line CME/CE]. Available FTP: http://www.medscape.com/viewarticle/495064

S10
Henry, C. and Washington, C&EN (2001 August 13). PHARMACOGENOMICS, Genetic markers such as single-nucleotide polymorphisms may lead to personalized medicines for a wide variety of diseases [64 paragraphs]. Chemical and Engineering News v79 (33) pp 37-42. [On-line journal]. Available FTP: http://pubs.acs.org/cen/coverstory/7933/7933pharmacogenomics.html

S11
Rauscher, M. (2006). Some People May be Genetically Susceptible to Chronic Fatigue [6 paragraphs]. Reuters Health Information [On-line information]. Available FTP: http://www.medscape.com/viewarticle/530400_print

S12
Hayney, M. (2002 October 9). Pharmacogenomics and Infectious Diseases: Impact on Drug Response and Applications to Disease Management [34 paragraphs]. Medscape from American Journal of Health-System Pharmacy 59(17): 1626-1631 [On-line journal]. Available FTP: http://www.medscape.com/viewarticle/442071

S13
Norton, R. (2001). Pharmacogenomics and Individualized Drug Therapy [38 paragraphs]. Medscape Pharmacotherapy 3(1), 2001. [On-line information]. Available FTP: http://www.medscape.com/viewarticle/408606

S14
Khoury, M. and Morris, J. (2006 May 8, Updated).Pharmacogenomics & Public Health: The Promise of Targeted Disease Prevention [4 paragraphs]. CDC, Genomics and Disease Prevention [On-line information]. Available FTP: http://www.cdc.gov/genomics/training/perspectives/factshts/pharmacofs.htm

S15
Barash, C. (2001). Ethical, Legal, and Social Implications of Genomic Research [12 paragraphs]. Medscape Pharmacotherapy 3(1), 2001 [On-line information]. Available FTP: http://www.medscape.com/viewarticle/408601

S16
Ross, J. and Ginsburg, G. (2003 February 14). The Integration of Molecular Diagnostics With Therapeutics [19 paragraphs]. Am J Clin Pathol 119(1):26-36, 2003. [On-line information]. Available FTP: http://www.medscape.com/viewarticle/447846

S17
(2004 May 30, Revised). Microarrays: Chipping Away At The Mysteries Of Science And Medicine [27 paragraphs]. National Center for Biotechnology Information [On-line information]. Available FTP: http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html

S18
Rados, C. (2005 November-December). Genomics and Medical Devices: A New Paradigm for Health Care [27 paragraphs]. FDA Consumer magazine [On-line information]. Available FTP: http://www.fda.gov/fdac/features/2005/605_devices.html

S19
(2004 December 23). FDA Clears First of Kind Genetic Lab Test [7 paragraphs]. FDA News [On-line information]. Available FTP: http://www.fda.gov/bbs/topics/news/2004/new01149.html

S20
(2006 February 9). Draft Guidance for Industry and FDA Staff - Pharmacogenetic Tests and Genetic Tests for Heritable Markers. FDA Center for Devices and Radiological Health [On-line Draft Guidance]. Available FTP: http://www.fda.gov/cdrh/oivd/guidance/1549.html

S21
(2005 August 22). FDA Clears Genetic Test That Advances Personalized Medicine. FDA OVID News Archive [On-line News Release]. Available FTP: http://www.fda.gov/cdrh/oivd/news.html#042706

S22
Freuh, F. (2005 April 26). Personalized Medicine: What is it? How will it affect health care? [47 pages]. 11th Annual FDA Science Forum [On-line presentation]. Available FTP: http://www.fda.gov/cder/genomics/scienceForum2005.pdf

S23
Meadows, M. (2005 November December) Genomics and Personalized Medicine [49 paragraphs] FDA Consumer Magazine [On-line information]. Available FTP: http://www.fda.gov/fdac/features/2005/605_genomics.html

S24
M. J. Kim, S. M. Huang, F. W. Frueh, A. N. Rahman, Y. M. Choi, K. M. Robie Suh, G. Shashaty, R. Rieves, L. J. Lesko, CDER, FDA, Silver Spring, MD (2006) Risk Management of Warfarin Overanticoagulation: Role of Pharmacogenomic Information. Available FTP: http://www.cfsan.fda.gov/~frf/forum06/K-16.htm

S25
M Wadelius, M Piromohamed, (2006). Pharmacogenetics of Warfarin: current status and future challenges. The Pharmacogenomics Journal, 1-13.